SUMMARY -Multiple sclerosis (MS) is one of the most common diseases of the central nervous system and usually occurs at the age when people would be expected to be in the prime of their sexual lives. In everyday practice, sexual dysfunction is underestimated because clinicians mostly concentrate on the classic neurologic defi cits and often overlook symptoms that can seriously aff ect the quality of life. Our study included 98 patients (42 men and 56 women, mean age 35±12 years) with relapse from our MS register, with established diagnosis of relapsing remitting multiple sclerosis according to McDonald criteria. Patients completed the questionnaires (Sexual Satisfaction Scale, SSS and Beck Depression Scale BDS), and underwent neurological assessment (Expanded Disability Status Scale, EDSS). All patients were in the group with EDSS 2 to 4 points (mobile patients). Th ere was no statistically signifi cant diff erence in BDS and SSS values according to EDSS score. Correlation coeffi cients were calculated (BDS and SSS) for men (p=0.42) and women (p=0.44), yielding positive correlation. Th ere was no statistically signifi cant diff erence in BDS and SSS values according to gender, disease duration or immunomodulatory therapy. In our group of patients, despite low EDSS score (fully ambulatory without aid, self suffi cient patients) we found positive correlation between sexual dysfunction and depression, showing that even in such patients the quality of life can be decreased. In conclusion, sexual dysfunction and depression are mostly under-recognized by neurologists because they are not part of routine testing; therefore, some additional questionnaires should be used in the evaluation in MS patients, even those with low EDSS score, in order to improve their quality of life.
Introduction
Multiple sclerosis (MS) is a chronic, infl ammatory, demyelinating disorder of the central nervous system (CNS) characterized by episodic and progressive neurologic dysfunction resulting from infl ammatory, autoimmune and neurodegenerative processes. According to McDonald MS criteria (introduced in 2001, revised in 2005 and 2010), MS can be divided into four clinical subtypes: relapsing remitting, secondary progressive, primary progressive, and progressive relapsing 1 . Although multiple sclerosis has historically been considered primarily aff ecting the CNS white matter, recent pathologic and imaging studies have established that demyelinated lesions are also commonly found in the cortical gray matter of MS patients. Lesions are disseminated throughout the CNS, but have a predilection for optic nerves, subpial spinal cord, brain stem, cerebellum, juxtacortical and periventricular white matter regions. Histologically, several processes drive the formation of MS plaques: infl ammation, myelin breakdown, astrogliosis, oligodendrocyte injury, neurodegeneration and remyelination 1, 2 .
Th e normal male sexual response cycle can be divided into libido (sexual desire), erection, ejaculation, orgasm and detumescence. In female, sexual response cycle has four elements, i.e. libido, arousal, orgasm and satisfaction. Th e integrity of the sexual response cycle is essential to human sexual response and functioning, and any damage may result in sexual dysfunction (SD).
Sexual arousal begins in the CNS, the brain sends messages to the sexual organs along the nerves running through the spinal cord (descending pathways), as well as receiving information from genital organs (ascending pathways). If MS damages these pathways, sexual response, including arousal and orgasm, can be directly aff ected (direct physical infl uence on SD). Sexual problems also stem from MS symptoms such as chronic pain, fatigue or spasticity, as well as dysfunction of urinary system (frequency, urgency, incontinence and obstructive symptoms) as indirect physical infl uence on SD. Also, it is of great importance to bear in mind that emotions are the result of complex functional circuits in the brain including interactions of the cortical, subcortical structures and limbic system. Sexual dysfunction can also arise from psychological factors relating to self-esteem and mood changes as a consequence of decreased quality of life and social functioning as emotional and cultural infl uence on SD. In large studies, depression was the most frequent SD comorbidity in MS patients [3] [4] [5] . Th e prevalence of SD in the general population is 31% in men and 43% in women. Multiple sclerosis is associated with an increased incidence of SD, present in 50%-75% of men and 40%-74% of women. Th e rate of major depressive disorder (MDD) in MS patients was found to be from 36% to 54% during lifetime. Th e syndrome refers to a collection of signs and symptoms underlain by low mood and inability to enjoy life as before. Th is change can be accompanied by a number of vegetative features (altered sleep, appetite, etc.) and distorted beliefs (feelings of guilt, worthlessness, life is not worth living, etc.). Both SD and depression are very often under-recognized, but have considerable impact on the patient quality of life. Th erefore, in the evaluation of patients with MS, it is of great importance to pay attention not only to functional defi cit, but also to mood changes, SD and quality of life [6] [7] [8] [9] [10] [11] . Due to the complexity and multifactorial nature of SD and its clinical manifestations, multidisciplinary approach is of great importance in MS patients, including neurologist, physical therapist, psychiatrist, urologist and educated nurses.
Patients and Methods
Th e present study included 98 patients aged 18-60 years from our Neurology Department MS register. All patients had established diagnosis of relapsing remitting multiple sclerosis according to McDonald criteria with EDSS score 0-4 (fully ambulatory patients).
Patients completed the questionnaires (Sexual Satisfaction Scale, SSS and Beck Depression Scale, BDS), and underwent neurological assessment (Expanded Disability Status Scale, EDSS). Before establishment of the MS diagnosis, patients had no psychiatric diagnosis or treatment. Patients were not taking antidepressants and there was no statistically signifi cant difference in taking other symptomatic therapy (pain, spasms, bladder and sphincter control).
Th e Sexual Satisfaction scale is based on the Sexual History Form (Nowinski and LoPiccolo, 1979). Four items from the Sexual History Form were selected to provide an indicator of overall sexual adjustment. Th ese items address the degree of satisfaction with physically expressing aff ection; the variety of sexual activities engaged in; and with the sexual relationship in general. Th e fourth item addresses the perceived level of satisfaction experienced by the partner within the relationship. Th is four-item scale is one of the components of the Multiple Sclerosis Quality of life (MSQ-LI). Raw scores on the 4 sexual satisfaction items (items 2-5) are summed to create total score. Th us, this scale can range from 4 to 24. Higher scores indicate greater problems with sexual satisfaction.
Th e Beck Depression Inventory (BDI, BDI-II), created by Dr. Aaron T. Beck, is a 21-question multiple-choice self-report inventory that is one of the most widely used instruments for measuring the severity of depression. Th e latest version of the questionnaire is designed for individuals aged 13 and over and is composed of items relating to depression symptoms such as hopelessness and irritability, cognitions such as guilt or feelings of being punished, as well as physical symptoms such as fatigue, weight loss, and lack of interest in sex. Th ere are three versions of the BDI: the original BDI fi rst published in 1961 and later revised in 1971 as BDI-1A, and the BDI-II published in 1996. Like BDI, the BDI-II also contains 21 questions, each an-swer being scored on a scale of 0 to 3. Th e cutoff s used diff er from the original: 0-13 = minimal depression; 14-19 = mild depression; 20-28 = moderate depression; and 29-63 = severe depression. Higher total scores indicate more severe depressive symptoms.
Th e Expanded Disability Status Scale (EDSS) is evaluating the degree of neurologic impairment in MS; it is a combination of grades (0 = normal to 5 or 6 = maximal impairment) within 8 Functional Systems (FS) and an overall Disability Status Scale (DSS) that have steps from 0 (normal) to 10 (death due to MS). Th e FS are Pyramidal, Cerebellar, Brain Stem, Sensory, Bowel & Bladder, Visual, Cerebral (Mental). Total EDSS score varies from 0-normal to 10-death due to MS.
Th e research was approved by the Sestre milosrdnice University Hospital Center Ethics Committee. All patients signed the informed consent form for participation in the study, as well as permission for publishing the data.
Results
All patients were in the group with EDSS 2 to 4 points (fully ambulatory patients) and all were young adults (interval 23-47 years). Th ere were 42 men and 56 women. Duration of the disease was 5±1.5 years. According to the level of education, there were 45% of patients with university degree, 37% with secondary school and 18% with elementary school. Most of the patients were single or divorced (no statistically signifi cant diff erences according to gender; p>0.05). Despite low EDSS score, only 23% of study patients were working full time, whereas almost two-thirds were working half time or retired/unemployed (Table 1) . Th ere was no statistically signifi cant diff erence in BDS and SSS values according to gender, disease duration or immunomodulatory therapy (p>0.05).
Symptoms of depression were identifi ed in 57% of patients (no gender diff erences; p>0.05), and symptoms of SD in 71% of patients (no gender diff erences; p>0.05). Most of men reported erectile dysfunction (31%), while the lack of sexual desire (20%) and orgasm problems (13%) were less frequently reported. In women, the lack of sexual desire was mostly frequently reported (25%), while orgasm problems (21%) and lubrication problems (20%) were less frequently reported.
Th e Beck Depression Scale score for both men and women was in the range for mild depression, and SSS score in the range for moderate SD (no diff erences according to gender; p>0.05).
Chronic fatigue was identifi ed n 64% (no gender diff erences), bladder and sphincter control disturbances in 34% (no gender diff erences), and spasticity in 42% of patients (no gender diff erences) (p>0.05 all). 
Discussion
Our study patients were young adults aged 23-47 and mobile, with EDSS score 2-4. Only one-third of patients were married and one-third had full time working hours. Th e incidence of depression was slightly higher in our study than in previous studies (57% vs. 50%), and SD was present at a high percentage, but not higher than in other studies (71% vs. 40%-75%). Th ese data indicate that despite low EDSS functional score which refl ects direct and indirect physical impact on SD, there is a high emotional and cultural infl uence on SD 12, 13 . We found positive correlation for both genders between depression and SD. Miscellaneous factors are involved in the incidence of depression and SD in MS patients. According to large studies, there does not appear to be clear genetic predisposition for major depression and SD in MS patients. Structural changes confi rmed on MRI of the brain and spine are in correlation with previously described pathomorphological and functional mechanisms of depression and SD. Psychosocial factors are of great importance in the evaluation of depression and SD in MS patients. A major limiting factor is that studies evaluating the impact of these factors are cross sectional, lacking follow up data [10] [11] [12] . Results of these studies have shown that the most important problem in the evaluation and treatment of MS patients with depression and SD is focus on emotion/state rather than the problem that has caused it. In order to resolve depressive mood and SD, a multidisciplinary approach should be used. Th e evaluation and treatment should also include functional status of the patient (EDSS score), as well as individual approach in planning medical treatment of MS, symptomatic treatment (bladder and sphincter control, pain, spasms) and coping strategies, recreational opportunities, improvement of relationships, and reduction of physical and psychical stress (chronic fatigue). In addition, it is of great importance to take in consideration disturbances of the hypothalamic-pituitary-adrenal axis, as well as the hypothalamic-pituitary-gonadal axis with disturbances of mood (depressive disorder) and SD as consequences 13 . Despite pronounced depression in MS patients, there are few well constructed psychopharmacological studies (the Cochrane Multiple Sclerosis Group's Trial Register contains only 2 studies the methodology of which, i.e. randomized, controlled, double blinded study, is considered appropriate). In these two studies, tricyclic antidepressants and serotonin reuptake inhibitors (SSRI) were proven to have positive impact on regression of depressive symptoms in MS patients versus placebo group. On subsequent screenings, patients reported fewer depressive symptoms regardless of whether a formal treatment recommendation was documented. Th ese fi ndings suggest that while depression screening does lead to depression related intervention in many cases, additional research is necessary to determine who is most likely to benefi t and under what conditions 13, 14 . In the evaluation of MS patients, depression and SD symptoms should be evaluated and appropriately treated with individual, but also multidisciplinary approach in order to improve their quality of life. Th ere is a need of follow up studies to evaluate the impact of diff erent physical, functional and psychosocial factors, as well as the impact of rehabilitation, immunomodulatory therapy and symptomatic therapy on long term outcome and quality of life in MS patients [14] [15] [16] .
